TP53 and breast cancer: Likewise, the added value of PV genes’ identification in the clinical management of BC patients is exemplified by the relative contraindication of radiation in patients with TP53 pathogenic variants (associated with Li-Fraumeni Syndrome), due to their higher risk of developing radiation-induced secondary cancers [30].